register

News & Trends - Pharmaceuticals

Medicines not mammograms are behind the reduction in breast cancer deaths

Health Industry Hub | June 29, 2020 |

Pharma News: A new Australian systemic review questioned whether population-based mammographic screening or endocrine therapy and chemotherapy (adjuvant therapy) after curative surgery for early or operable breast cancer were associated with the decline in breast cancer mortality.

The decline is breast cancer deaths in the last 20 years can be attributed to the use of therapies such as tamoxifen and chemotherapy, and not to the mammogram screening program, according to an analysis of Victorian women.

The study found that the mammogram screening program did not result in more breast cancer in Victoria being detected at an early rather than an advanced stage, so there was no population mortality benefit. Crude breast cancer mortality declined by 30% after 1994 and the researchers say this was all linked to adjuvant and chemotherapy therapy uptake and not screening.

The authors conclude that BreastScreen should be ceased as persistence with the program may continue to expose women to unnecessary morbidity and mortality.


News & Trends - Pharmaceuticals

Clinical and Laboratory Haematologist and Lead of the Molecular Haematology Service

Clinicians call for closer monitoring of patients post CAR T therapy

Health Industry Hub | February 17, 2025 |

Australian clinicians are raising questions about whether cancer patients need closer monitoring after receiving CAR T-cell therapy. A Peter MacCallum […]

More


News & Trends - MedTech & Diagnostics

Next-gen surgical mesh to fill critical gap after ban

Next-gen surgical mesh to fill critical gap after regulatory ban

Health Industry Hub | February 17, 2025 |

Next-generation urogynaecological surgical mesh implants are on the horizon for women suffering from pelvic organ prolapse (POP). This development aims […]

More


News & Trends - Pharmaceuticals

Contraceptive lawsuit against Bayer fails

Contraceptive lawsuit against Bayer fails

Health Industry Hub | February 17, 2025 |

The Victorian Supreme Court has dismissed a class action against Bayer for an allegedly defective contraceptive device. Justice Andrew Keogh […]

More


News & Trends - Pharmaceuticals

NSW Government ignored warnings since 2018: Mental health system unravels as psychiatrists quit en masse

NSW Government ignored warnings since 2018: Mental health system unravels as psychiatrists quit en masse

Health Industry Hub | February 17, 2025 |

The New South Wales Labor government’s plan to “redesign” the state’s mental health system, while excluding psychiatrists, has sparked intense […]

More


This content is copyright protected. Please subscribe to gain access.